Axon Enterprise Inc
NASDAQ:AXON
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
244.21
689.78
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Axon Enterprise Inc
Axon Enterprise Inc
Cost of Revenue
Axon Enterprise Inc
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Axon Enterprise Inc
NASDAQ:AXON
|
Cost of Revenue
-$980.8m
|
CAGR 3-Years
-45%
|
CAGR 5-Years
-38%
|
CAGR 10-Years
-33%
|
|
|
Boeing Co
NYSE:BA
|
Cost of Revenue
-$71B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
1%
|
CAGR 10-Years
1%
|
|
|
TransDigm Group Inc
NYSE:TDG
|
Cost of Revenue
-$3.3B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-12%
|
|
|
Lockheed Martin Corp
NYSE:LMT
|
Cost of Revenue
-$62.6B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-5%
|
|
|
General Dynamics Corp
NYSE:GD
|
Cost of Revenue
-$38.8B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-5%
|
|
|
Raytheon Technologies Corp
NYSE:RTX
|
Cost of Revenue
-$63.9B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-31%
|
CAGR 10-Years
-4%
|
|
Axon Enterprise Inc
Glance View
Axon Enterprise Inc., originally known as Taser International, has evolved significantly since its founding in 1993, crafting a narrative of innovation that reshapes public safety. The company, famous for its electronic stun devices, has expanded far beyond its initial offerings, seamlessly intertwining technology with law enforcement to create a comprehensive suite of products. At the core of Axon's operations lies its commitment to advancing safety and transparency without resorting to lethal force. The move from solely producing Tasers to developing a range of body-worn cameras and cloud-based evidence management software demonstrates a strategic pivot towards becoming a holistic solution provider for law enforcement agencies. This evolution is not merely about diversifying products but crafting a broader ecosystem that supports the modern needs of policing, aiming to arm officers with real-time, actionable insights while ensuring accountability. Revenue generation for Axon is multifaceted, embodying a blend of hardware sales, recurring subscriptions, and service contracts. The company's financial engine runs efficiently on the recurring revenue model, particularly through Axon Evidence (formerly Evidence.com), its proprietary cloud platform. This platform allows law enforcement agencies to store, manage, and share digital evidence securely, offering a subscription service that has become an essential tool amidst the growing demand for accountability and transparency in policing. Furthermore, Axon's strategic use of software-as-a-service (SaaS) complements its hardware sales, providing a steady, predictable financial stream. The synergy between selling physical goods like Tasers and cameras, paired with ongoing digital service contracts, showcases Axon's adeptness in crafting a business model that leverages both upfront hardware purchases and long-term software subscriptions.
See Also
What is Axon Enterprise Inc's Cost of Revenue?
Cost of Revenue
-980.8m
USD
Based on the financial report for Sep 30, 2024, Axon Enterprise Inc's Cost of Revenue amounts to -980.8m USD.
What is Axon Enterprise Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-33%
Over the last year, the Cost of Revenue growth was -72%. The average annual Cost of Revenue growth rates for Axon Enterprise Inc have been -45% over the past three years , -38% over the past five years , and -33% over the past ten years .
You don't have any saved screeners yet